Results 181 to 190 of about 697,518 (243)
Pediatric Gastrointestinal Tract Outcomes During the Postacute Phase of COVID-19.
Zhang D+28 more
europepmc +1 more source
Abstract Background Bireociclib (XZP‐3287) is a novel selective cyclin‐dependent kinase 4 and 6 (CDK4/6) inhibitor, with a favorable safety profile demonstrated in preclinical and phase I studies. BRIGHT‐1 aimed to further explore the efficacy and safety of bireociclib monotherapy in patients with locally advanced, recurrent or metastatic, hormone ...
Jiayu Wang+18 more
wiley +1 more source
Effective doses received by the gastrointestinal tract compartments of adults due to food intake in Egypt. [PDF]
Abdalbasit Y+3 more
europepmc +1 more source
Forrest-type IIb increases the risk of rebleeding after endoscopic treatment in patients with Dieulafoy's lesion of the upper gastrointestinal tract. [PDF]
Qiu J+9 more
europepmc +1 more source
Abstract Background The epidemiological profiles of gastrointestinal (GI) cancers vary across countries and over time, largely reflecting variations in risk factors and screening practices. We aimed to provide an overview of the current global burden of the five major types of GI cancers and conduct an updated evaluation of the long‐term trends of GI ...
Mengmeng Li, Sumei Cao, Rui‐Hua Xu
wiley +1 more source
Prehabilitation during neoadjuvant therapy in patients with cancer of the upper gastrointestinal tract and rectum-the study protocol. [PDF]
Chmelova I+10 more
europepmc +1 more source
Efficacy and Safety of CART Cell Therapy in Aggressive B-Cell Lymphomas Involving the Gastrointestinal Tract. [PDF]
Ma L+12 more
europepmc +1 more source
Analysis of ROMO1 Expression Levels and Its Oncogenic Role in Gastrointestinal Tract Cancers. [PDF]
Yaman S+4 more
europepmc +1 more source